IP International Journal of Comprehensive and Advanced Pharmacology,
Год журнала:
2024,
Номер
9(4), С. 219 - 220
Опубликована: Ноя. 15, 2024
Nano-encapsulated
CRISPR-based
genome:
Next-generation
strategies
to
optimize
delivery
-
IJCAAP-
Print
ISSN
No:
2581-5555
Online
No:-
2456-9542
Article
DOI
10.18231/j.ijcaap.2024.032,
IP
International
Journal
of
Comprehensive
and
Advanced
Pharmacology-IP
Int
J
Compr
Adv
Pharmacol
Pharmaceutics,
Год журнала:
2024,
Номер
16(6), С. 709 - 709
Опубликована: Май 24, 2024
Of
all
the
numerous
nanosized
extracellular
vesicles
released
by
a
cell,
endosomal-originated
exosomes
are
increasingly
recognized
as
potential
therapeutics,
owing
to
their
inherent
stability,
low
immunogenicity,
and
targeted
delivery
capabilities.
This
review
critically
evaluates
transformative
of
exosome-based
modalities
across
pharmaceutical
precision
medicine
landscapes.
Because
precise
biomolecular
cargo
delivery,
posited
ideal
candidates
in
drug
enhancing
regenerative
strategies,
advancing
diagnostic
technologies.
Despite
significant
market
growth
projections
exosome
therapy,
its
utilization
is
encumbered
substantial
scientific
regulatory
challenges.
These
include
lack
universally
accepted
protocols
for
isolation
complexities
associated
with
navigating
environment,
particularly
guidelines
set
forth
U.S.
Food
Drug
Administration
(FDA).
presents
comprehensive
overview
current
research
trajectories
aimed
at
addressing
these
impediments
discusses
prospective
advancements
that
could
substantiate
clinical
translation
exosomal
therapies.
By
providing
analysis
both
capabilities
hurdles
therapeutic
applications,
this
article
aims
inform
direct
future
paradigms,
thereby
fostering
integration
systems
into
mainstream
practice.
Some
of
the
most
crucial
turning
points
in
treatment
strategies
for
some
major
infectious
diseases
including
AIDS,
malaria,
and
TB,
have
been
reached
with
introduction
antimicrobials
vaccines.
Drug
resistance
poor
effectiveness
are
key
limitations
that
need
to
be
overcome.
Conventional
liposomes
explored
as
a
delivery
system
bioactives
treat
provide
an
efficient
approach
maximize
therapeutic
outcomes,
drug
stability,
targetability,
reduce
side-effects
antimicrobials,
enhance
vaccine
performance
where
necessary.
However,
pathological
understanding
become
more
known,
advanced
liposomal
technologies
was
born
continue
having
profound
effect
on
targeted
chemotherapy
diseases.
This
review
therefore
provides
concise
incursion
into
recent
vogue
formulations
used
An
appraisal
immunological,
stimuli-responsive,
biomimetic
functionalized
other
novel
modifications
conventional
is
assimilated
sync
mutations
resistant
pathogens.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(5), С. 2927 - 2927
Опубликована: Март 2, 2024
Ischemic
stroke
is
associated
with
a
high
mortality
rate,
and
effective
treatment
strategies
are
currently
lacking.
In
this
study,
we
aimed
to
develop
novel
nano
delivery
system
treat
ischemic
via
intranasal
administration.
A
three-factor
Box–Behnken
experimental
design
was
used
optimize
the
formulation
of
liposomes
co-loaded
Panax
notoginseng
saponins
(PNSs)
Ginsenoside
Rg3
(Rg3)
(Lip-Rg3/PNS).
Macrophage
membranes
were
coated
onto
surface
optimized
target
site
brain.
The
double-loaded
disguised
by
macrophage
(MM-Lip-Rg3/PNS)
spherical,
in
“shell–core”
structure,
encapsulation
rates
81.41%
(PNS)
93.81%
(Rg3),
showed
good
stability.
vitro,
MM-Lip-Rg3/PNS
taken
up
brain
endothelial
cells
clathrin-dependent
endocytosis
micropinocytosis
pathways.
Network
pharmacology
experiments
predicted
that
could
regulate
multiple
signaling
pathways
reducing
apoptosis
inflammatory
responses.
After
14
days
MM-Lip-Rg3/PNS,
survival
weight,
neurological
score
middle
cerebral
artery
occlusion
(MCAO)
rats
significantly
improved.
hematoxylin
eosin
(H&E)
TUNEL
staining
results
can
reduce
neuronal
cell
infiltration
protect
vivo
biological
have
shown
free
Rg3,
PNS,
alleviate
inflammation
apoptosis,
especially
indicating
biomimetic
improve
therapeutic
effects
drugs.
Overall,
potential
targeted
for
therapy.
Frontiers in Bioengineering and Biotechnology,
Год журнала:
2025,
Номер
12
Опубликована: Янв. 8, 2025
Myocardial
infarction
(MI)
is
the
leading
cause
of
morbidity
and
mortality
worldwide.
Curcumin
has
been
observed
to
significantly
reduce
pathological
processes
associated
with
MI.
Its
clinical
application
limited
due
its
low
bioavailability,
rapid
degradation,
poor
solubility.
Advancements
in
nanotechnology
can
be
used
enhance
therapeutic
potentials
nano-formulation
enhances
solubility,
stability,
allowing
more
precise
delivery
ischemic
cardiac
tissue.
nanoparticles
have
successfully
infarct
size,
maintain
heart
function
by
modulating
essential
molecular
pathways
liposomal
formulations
provide
sustained
release
higher
tissue
penetration
improved
pharmacokinetics
enhanced
efficacy.
Preclinical
studies
revealed
that
nanocurcumin
drastically
lower
oxidative
stress
indicators,
inflammatory
cytokines,
damage.
Micelles
composed
polymers
demonstrated
high
biocompatibility
targeting
capabilities
increased
cardio-protective
effects.
Research
trials
are
for
comprehensive
analysis
efficacy
curcumin-based
nano-therapeutics
cardiovascular
condition
lowering
risk
Frontiers in Nanotechnology,
Год журнала:
2025,
Номер
6
Опубликована: Янв. 22, 2025
Extracellular
vesicles
(EVs),
natural
membrane-bound
structures
released
by
cells,
offer
a
promising
platform
for
precise
and
targeted
delivery
of
therapeutic
payloads,
including
drugs
nanoparticles.
This
comprehensive
review
explores
the
integration
engineered
nanomaterials
with
EVs
to
advance
drug
systems.
It
covers
various
aspects
this
integration,
techniques
synthesizing,
loading,
characterizing,
applying
within
EVs.
Methodologies
integrating
diverse
nanocarriers
like
nanoparticles,
liposomes,
quantum
dots
into
are
discussed,
along
characterization
methods
such
as
electron
microscopy
light
scattering.
Attention
is
also
given
considerations
biological
compatibility,
safety
assessments,
strategies
surface
modification
enhance
targeting
precision.
Highlighting
applications,
delivery,
cancer
therapy,
vaccine
development,
underscores
potential
EV-nanomaterial
hybrids
leverage
EVs’
innate
capabilities
versatility
nanomaterials.
However,
it
addresses
challenges
scalability,
standardization,
that
must
be
overcome
facilitate
clinical
translation
these
biomedical
solutions.
Nanomedicine
offers
fresh
approaches
for
breast
cancer
treatment,
countering
traditional
limitations.
The
nanodrug
delivery
system's
precision
and
biocompatibility
hold
promise,
yet
integration
hurdles
remain.
This
study
reviews
nano
systems
in
therapy
from
2013
to
2023,
guiding
future
research
directions.
In
this
study,
we
conducted
a
comprehensive
search
on
Web
of
Science
database
(Guilin
Medical
University
purchase
edition)
downloaded
literature
related
the
field
published
between
2023.
We
analyzed
these
publications
using
R
software,
VOSviewer,
CiteSpace
software.
reviewed
2632
documents,
showing
steady
publication
increase
peaking
at
408
2022.
China,
USA,
India,
Iran
were
prominent
publishing.
Chinese
Academy
Sciences
Tabriz
key
collaboration
centers.
Notably,
Journal
Controlled
Release
Biomaterials
ranked
among
top
10
journals
citations,
establishing
their
representation.
Key
terms
like
"breast
cancer,"
"nanoparticles,"
"drug
delivery,"
"in-vitro,"
"delivery"
widely
used.
Research
focused
optimizing
drug
targeting,
utilizing
tumor
microenvironment
delivery,
improving
efficiency.
system,
as
an
innovative
approach,
numerous
advantages
has
garnered
global
attention
researchers.
provides
analysis
status
hotspots
within
realm
therapy,
offering
valuable
insights
domain.